FDA approves first U-500 insulin pen device

FDA has cleared the first prefilled pen device containing concentrated U-500 strength insulin (Humulin R U-500 KwikPen—Eli Lilly) for diabetes patients who require more than 200 units per day. The new device is a more convenient alternative to the current U-500 vial, which requires use of a syringe and dose conversions.